GW-501516 Cardarine Sarms Weight Loss
Alias:2-(4-((2-(4-(Trifluoromethyl)phenyl)-5-methylthiazol-4-yl)methylthio)-2-methylphenoxy)acetic acid; GW1516; GW501516; GSK-516
Usage: It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. GW501516 could be used by athletes as an ergogenic performance enhancing drug.
Ostarine, MK-2866, Enobosarm
Enobosarm (Ostarine, MK-2866, GTx-024) - affects both muscle and bone, intended mainly for osteoporosis but also general
treatment for andropause and reversing muscle sarcopenia in the elderly and for cachexia in cancer patients.
Pharmacological profile similar to that of enobosarm, Ostarine, MK-2866
MK-677, Ibutamoren, secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly
Partial agonist, intended mainly for treatment of benign prostatic hypertrophy
It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease
AICAR acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown
Whatsapp : 8618038192043